April 29, 2020 / 9:31 PM / a month ago

BRIEF-IGM Biosciences, Atreca, Beigene To Collaborate To Help Address Covid-19

April 29 (Reuters) - Beigene Ltd:

* IGM BIOSCIENCES INC - ATRECA, INC. BEIGENE, LTD. AND IGM BIOSCIENCES, INC. ANNOUNCED THEIR PLANS TO COLLABORATE TO HELP ADDRESS COVID-19 PANDEMIC

* IGM BIOSCIENCES - ATRECA, BEIGENE, CO TO DISCOVER, DEVELOP, MANUFACTURE NOVEL IGM, IGA ANTIBODIES TARGETING SARS-COV-2 FOR POTENTIAL TREATMENT OF COVID-19

* IGM BIOSCIENCES INC - PARTIES HAVE AGREED TO BEGIN WORK IMMEDIATELY AND PLAN TO FINALIZE FINANCIAL DETAILS AND OTHER TERMS IN FUTURE

* IGM BIOSCIENCES - ATRECA, IGM HAVE ENTERED TRANSFER AND COLLABORATION AGREEMENT TO ENABLE PARTIES TO BEGIN WORKING TOGETHER IMMEDIATELY

* IGM BIOSCIENCES INC - ATRECA, IGM, AND BEIGENE PLAN TO DISCUSS FURTHER TERMS AND ARRANGEMENTS IN FUTURE

* IGM BIOSCIENCES - IF RESEARCH, MANUFACTURING, REGULATORY ACTIVITIES PROCEED VERY WELL, COS BELIEVE ANTIBODY MAY BE READY TO BEGIN TESTING IN H1 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below